MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_Stem Cell Therapeutics
Corestem
Organization & Developments: Corestem
Parents
Corestem
Children
CORESTEM is a biotechnology company specializing in the research and development of personalized stem cell therapies for neurological and autoimmune diseases.
CORESTEM launched the world’s first stem cell therapy for amyotrophic lateral sclerosis in South Korea in 2015.
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS).
The company is now seeking out-licensing partners as it works toward product approvals in the US and Europe.
Jumps
Finance & Acquisitions: Corestem
Key People: Corestem